SunnyBay BioTech

Fremont, United States

SunnyBay BioTech develops therapeutic antibodies to detect, diagnose, and treat cancer.

$2.2M raised

Jan 2023

Venture - Series Unknown

Biotechnology Health Care Medical Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SunnyBay BioTech

How much funding has SunnyBay BioTech raised?

SunnyBay BioTech has raised $2.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2023.

Where is SunnyBay BioTech headquartered?

SunnyBay BioTech is headquartered in Fremont, United States.

What does SunnyBay BioTech do?

SunnyBay BioTech develops therapeutic antibodies to detect, diagnose, and treat cancer.

What stage is SunnyBay BioTech at?

SunnyBay BioTech is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 26, 2023.

MLA

"SunnyBay BioTech — Funding & Investors." VCBacked, January 26, 2023, https://www.vcbacked.co/company/sunnybay-biotech. Accessed July 2, 2026.

APA

VCBacked. (2023). SunnyBay BioTech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sunnybay-biotech

Wikipedia (cite web)

{{cite web |title=SunnyBay BioTech — Funding & Investors |url=https://www.vcbacked.co/company/sunnybay-biotech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 26, 2023.